AFP and hepatocellular carcinoma: In another study conducted by Hu et al. on a cohort of 357 patients with different stages of virus C infection without HCC, the prevalence of elevated serum AFP (>10μg/l) was 23%, 24.5% and 42% in hepatic fibrosis stages 0-II, III and IV, respectively [15].